Press release
Ecully, 20 March 2014
SPINEWAY will be participating in the Smallcap Event
on 7 and 8 April 2014
Spineway, a specialist in high-tech surgical implants and ancillary equipment for the treatment of vertebral column (spinal) pathologies, will be participating in the 9th edition of the European Smallcap Event that will be held in Paris on 7 and 8 April 2014.
During the course of these two days, Stéphane Le Roux, President of Spineway, Philippe Laurito, CEO, and David Siegrist, CFO, will meet with investors one-on-one in order to present Spineway and its development prospects.
This is the ninth year the European Smallcap Event will bring together institutional investors and financial managers and analysts with SMEs admitted to listing on the stock market. This event, conceived and hosted by CF&B Communication, makes it possible for over one hundred listed companies to meet with European experts in small-cap companies (with a market capitalization of under 500 million euros).
European Smallcap Event
Hôtel Pullman Tour Eiffel
18 avenue de Suffren
75015 PARIS
SPINEWAY is compliant with the PEA PME (French SME-invested savings plan)
For more information, please go to www.spineway.com
Spineway designs, manufactures and sells lines of innovative surgical implants and ancillary equipment for the treatment of severe spinal column pathologies.
Spineway has a worldwide network, with 48 independent distributors, and 90% of its revenue is from exports.
Spineway, which is compliant with the FCPI French fund, has received the OSEO Excellence award since 2011 and is a Deloitte Fast 50 winner (2011). INPI Rhône Alpes Politique patent award (2013).
Contacts:
 |  | |
| Investor relations David Siegrist - Financial Director Phone: +33 (0)4 72 77 01 52 finance.dsg@spineway.com |  | Financial communications Jérôme Gacoin / Solène Kennis Phone: +33 (0)1 75 77 54 68 skennis@aelium.fr |
